Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.
about
Adherence to antiretroviral therapy: merging the clinical and social course of AIDS.Community-based approaches for prevention of mother to child transmission in resource-poor settings: a social ecological reviewPatient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapyNonadherence to primary prophylaxis against Pneumocystis jirovecii pneumoniaImaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.Prevalence and predictors of posttraumatic stress disorder and depression in HIV-infected and at-risk Rwandan women.INtegration of DEPression Treatment into HIV Care in Uganda (INDEPTH-Uganda): study protocol for a randomized controlled trial.Neuropsychiatric manifestations of HIV infection and AIDSCost of Care for HIV-Infected Patients with Co-Occurring Substance Use Disorder or Psychiatric Disease: Report from a Large, Integrated Health PlanIs antiretroviral therapy adherence substantially worse on weekends than weekdays?Reliability and validity of depression assessment among persons with HIV in sub-Saharan Africa: systematic review and meta-analysis.Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression.Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study.Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users.Sensorimotor dysfunction in HIV/AIDS: effects of antiretroviral treatment and comorbid psychiatric disordersFour types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time.Reliability and validity of the Haitian Creole PHQ-9.Bidirectional links between HIV and intimate partner violence in pregnancy: implications for prevention of mother-to-child transmissionProject Masihambisane: a cluster randomised controlled trial with peer mentors to improve outcomes for pregnant mothers living with HIV.Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic.Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in UgandaThe association of health-related quality of life with survival among persons with HIV infection in the United States.A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program.Individual and contextual factors of influence on adherence to antiretrovirals among people attending public clinics in Rio de Janeiro, BrazilBenefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.Food insecurity, depression, and social support in HIV-infected Hispanic individualsPredictors of screening results for depressive symptoms among homeless adults in Los Angeles with latent tuberculosis.Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problemsHIV, violence and women: unmet mental health care needs.Quality of sleep: associations with antiretroviral nonadherenceThe prevalence and clinical presentation of antenatal depression in rural South AfricaA closer look at depression and its relationship to HIV antiretroviral adherence.The validity of the Patient Health Questionnaire for screening depression in chronic care patients in primary health care in South AfricaEffectiveness of antidepressants and predictors of treatment response for depressed HIV patients in Uganda.Perceived burden in adherence of antiretroviral treatment in rural ChinaReligion, spirituality, and depressive symptoms in patients with HIV/AIDSValidating the Children's Depression Inventory in the context of RwandaPrevalence and correlates of probable common mental disorders in a population with high prevalence of HIV in ZimbabweHIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.
P2860
Q24810599-CA0E4059-C2AB-4924-8F8F-13E96074AE92Q26828887-F3E6803F-B07C-496B-BA42-C9374AAF16B1Q28469228-13937680-CFCA-4822-A830-05B834CD93D4Q30859949-35C86BE5-60FB-43B0-87AB-0E2F5D173942Q33637117-6785D6EA-BF69-4E24-99BA-E18315DC6FFCQ33686675-422E4B62-CDB9-44AD-BC79-08A43439C4DFQ33851316-13D4C6C8-5C91-40B4-A882-2EDDB74E09F1Q33868874-E2AD6D79-DFFE-4574-909D-07B759E45DDFQ33876681-EAB88E15-019E-4602-A337-2CAAFE77208FQ33891127-F4E34FC1-C7DD-44DB-8B81-F456C9FC0590Q33894019-5B2D4ACF-A96F-417F-98EC-A7FC84E70135Q33894714-4768733F-96FB-4BF3-BC7E-C53E50368223Q33902792-9A0301C2-923D-42DE-B772-A8B067430290Q33935784-FB3B873F-14FD-4175-8C55-3161777E94E3Q33939975-4F75ADCA-4A15-4A6D-AA0D-B239624E746BQ34081652-87491150-1F73-4B21-957A-BDB90B2CD9B0Q34373751-5616BC47-5BB5-4AE8-8411-51C0DD095A6FQ34432290-4D945DBE-188A-4BC1-88F6-517C5AE1EBADQ34451568-6DCEFE77-D673-413C-8C46-E538673B8092Q34499412-D0930571-81EA-4D9F-93C5-E4BB53769535Q34500577-8EB9E3EA-1F8B-4417-9788-BB93B5D07D3BQ34611305-3BD16824-00E6-4C54-AF1A-4097C32EDC6FQ34722605-8B09F808-290B-40C8-A41F-AC1D4B80E16FQ34749709-15E2EBC1-D105-4BCF-9D5D-1E846A9D49E4Q34768318-62E9116F-24F1-4076-9603-56C00B36D54AQ34845860-CD152DBA-A6C3-48C2-A315-B216584BA559Q35002198-0BD801C1-D2A6-406A-8FB9-9BB77A63CE4AQ35030060-75501A5C-45E8-41A7-BE2E-3FC7340C2468Q35069899-B80EE4EF-0A8E-418A-8063-37E7FD123644Q35122334-57B4D965-8772-41DA-B104-FAE5F2D970CBQ35168316-867A6B20-F7A6-442B-A8F2-8628E12DB884Q35535707-0E0E55BE-F25C-48EE-A272-36F10B2B6A67Q35580641-504A63C1-C373-43D2-81C1-1CB26CDF0BA7Q35639736-0B23632E-5EAB-49E0-A5B0-8FF95F611402Q35756593-98C6D799-42CE-4937-B8DB-9B7A80EDB1D1Q35884197-EC1C79B6-5BE2-4D44-9FD0-866B11F2C3B3Q35901766-2BA6BAE2-E8F0-47FE-961C-84F316FA5B74Q35929609-050F8619-5594-44FA-B0EB-A759A40AA38CQ35939679-C92FA4B9-D241-4D92-BF37-E97DAE604313Q35957349-33785DA2-21FA-4609-BAD5-E5AE449E402A
P2860
Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Depression is a risk factor fo ...... active antiretroviral therapy.
@ast
Depression is a risk factor fo ...... active antiretroviral therapy.
@en
type
label
Depression is a risk factor fo ...... active antiretroviral therapy.
@ast
Depression is a risk factor fo ...... active antiretroviral therapy.
@en
prefLabel
Depression is a risk factor fo ...... active antiretroviral therapy.
@ast
Depression is a risk factor fo ...... active antiretroviral therapy.
@en
P2093
P1476
Depression is a risk factor fo ...... active antiretroviral therapy.
@en
P2093
AdICoNA Study Group. NeuroICoNA Study Group
Adriana Ammassari
Albert W Wu
Alfredo Scalzini
Crescenzo Izzo
Fabrizio Starace
Maria Paola Trotta
Patrizio De Longis
Rita Murri
P304
P407
P478
31 Suppl 3
P577
2002-12-01T00:00:00Z